Associate Creative Director

The posting, as BillionToOne wrote it

A Rare Opportunity to Shape the Future of Genomics

Join a team of brilliant, passionate innovators determined to transform healthcare. At BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. We don't just aim for incremental improvements; we build products that are 10x better than anything that exists today.

Our scientists, engineers, sales executives, and visionaries are united by an unwavering commitment to changing the standard of care in prenatal and cancer diagnostics. This is where cutting-edge science meets human compassion, and every innovation you contribute helps remove the fear of the unknown from some of life's most critical medical moments.

If you're driven by purpose, energized by innovation, and ready to help shape the future of precision medicine at scale, this is where you belong.

BillionToOne is seeking an exceptional Associate Creative Director (Prenatal) to lead creative strategy and execution across our product, sales, and marketing initiatives. This role sits at the intersection of cutting-edge science and compelling visual storytelling—translating complex science into clear, engaging narratives that resonate with providers, clinicians, patients, and partners.

• Brand Development & Campaigns: Lead brand development and communication strategy for Unity, our prenatal genetic portfolio product line. Develop creative strategy and art direction for social media content, event activations, experience design, and outdoor advertising. Create provider- and patient-facing brand advertising, product marketing, and sales enablement content across display, social, video, and experiential channels.
• Strategic Design Leadership: Partner with Product, Sales, and Marketing to define project objectives, translating requested outputs into measurable business outcomes. Develop creative strategies informed by insights into what drives behavior across providers, patients, and industry partners. Break down complex creative work into plans that align with business goals and timelines.
• Art, Copy & Messaging: Direct art, copy, and message development, balancing scientific accuracy with emotional resonance and accessibility.
• Creative Direction & Execution: Lead art direction across print, digital, video, animation, presentations, environmental graphics, and branded experiences. Transform complex scientific concepts—including molecular diagnostics, genetic testing, and laboratory workflows—into compelling visual narratives.
• Design Systems & Brand Guidelines: Establish and evolve design systems and brand guidelines that scale with our rapid company growth.
• Creative Production: Direct photography, illustration, motion graphics, and video production with internal teams and external vendors.
• Team Leadership & Development: Guide a

[…]
l status, veteran status, or disability status.
For more information about how we protect your information, we encourage you to review our Privacy Policy .

BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. Our revolutionary QCT molecular counting technology enhances disease detection resolution by over a thousandfold using cell-free DNA,a breakthrough that has already transformed the lives of over half a million patients worldwide.

Our Impact

Unity Complete™ is the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample.
Unity Confirm™ enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture™ Technology.
Our Northstar® liquid biopsy test uniquely combines treatment selection with real-time monitoring, giving oncologists unprecedented precision in cancer care.

Our Growth

From $0 to $400M+ annualized revenue run-rate in just 6 years. In 2025, we completed one of the most successful IPOs for a medical diagnostics company, building on nearly $400M in private funding,including our $130M Series D in 2024 and backed by world-class investors including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest.

Our Recognition

Forbes named us one of America's Best Startup Employers for 2025 and we're Great Place to Work certified , with 100% of our people willing to go the extra mile, even as we've scaled to over 700 employees.

Our Future

Headquartered in Menlo Park with facilities in Union City, CA, and a new lab opening in Austin, TX in 2027, we're continuing to push the boundaries of what's possible in molecular diagnostics. We're just getting started.

Ready to help us change the world, one molecule at a time? Learn more at billiontoone.com